AT258875B - Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate - Google Patents

Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate

Info

Publication number
AT258875B
AT258875B AT956163A AT956163A AT258875B AT 258875 B AT258875 B AT 258875B AT 956163 A AT956163 A AT 956163A AT 956163 A AT956163 A AT 956163A AT 258875 B AT258875 B AT 258875B
Authority
AT
Austria
Prior art keywords
preparation
new
aminopropionamide
derivatives
aminopropionamide derivatives
Prior art date
Application number
AT956163A
Other languages
German (de)
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of AT258875B publication Critical patent/AT258875B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Paper (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT956163A 1962-12-01 1963-11-29 Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate AT258875B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1414962 1962-12-01

Publications (1)

Publication Number Publication Date
AT258875B true AT258875B (de) 1967-12-11

Family

ID=4398397

Family Applications (1)

Application Number Title Priority Date Filing Date
AT956163A AT258875B (de) 1962-12-01 1963-11-29 Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate

Country Status (3)

Country Link
AT (1) AT258875B (cg-RX-API-DMAC10.html)
BE (1) BE640639A (cg-RX-API-DMAC10.html)
GB (1) GB1072118A (cg-RX-API-DMAC10.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664848A (en) 1982-12-23 1987-05-12 The Procter & Gamble Company Detergent compositions containing cationic compounds having clay soil removal/anti-redeposition properties
EP2476756A1 (en) 2005-06-15 2012-07-18 Massachusetts Institute of Technology Amine-containing lipids and uses thereof
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
ME03327B (me) 2009-12-01 2019-10-20 Translate Bio Inc Stereoidni derivati za isporuku irnk u humanim genetskim oboljenjima
US9193827B2 (en) 2010-08-26 2015-11-24 Massachusetts Institute Of Technology Poly(beta-amino alcohols), their preparation, and uses thereof
EP2691443B1 (en) 2011-03-28 2021-02-17 Massachusetts Institute of Technology Conjugated lipomers and uses thereof
CN103906527B (zh) 2011-06-08 2020-07-10 川斯勒佰尔公司 Mrna递送的脂质纳米颗粒组合物和方法
WO2013185067A1 (en) 2012-06-08 2013-12-12 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
CA2884870C (en) 2012-08-13 2022-03-29 Massachusetts Institute Of Technology Amine-containing lipidoids and uses thereof
CN105051190A (zh) 2013-03-14 2015-11-11 夏尔人类遗传性治疗公司 信使rna的纯化方法
HUE042640T2 (hu) 2013-03-14 2019-07-29 Translate Bio Inc CFTR-mRNS-készítmények, valamint kapcsolódó eljárások és alkalmazások
US9315472B2 (en) 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
CA2928188A1 (en) 2013-10-22 2015-04-30 Shire Human Genetic Therapies, Inc. Mrna therapy for argininosuccinate synthetase deficiency
AU2014340155B2 (en) 2013-10-22 2018-11-01 Massachusetts Institute Of Technology Lipid formulations for delivery of messenger RNA
EA201992208A1 (ru) 2013-10-22 2020-07-31 Транслейт Био, Инк. ЛЕЧЕНИЕ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
JP6571679B2 (ja) 2014-04-25 2019-09-04 トランスレイト バイオ, インコーポレイテッド メッセンジャーrnaの精製方法
CA3211902A1 (en) 2014-05-30 2015-12-03 Translate Bio, Inc. Biodegradable lipids for delivery of nucleic acids
CA2952824C (en) 2014-06-24 2023-02-21 Shire Human Genetic Therapies, Inc. Stereochemically enriched compositions for delivery of nucleic acids
EP3164379A1 (en) 2014-07-02 2017-05-10 Massachusetts Institute of Technology Polyamine-fatty acid derived lipidoids and uses thereof
MX2019010155A (es) 2017-02-27 2020-12-10 Translate Bio Inc Arnm de cftr optimizado por codón novedoso.
US11173190B2 (en) 2017-05-16 2021-11-16 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
EP3841208A1 (en) 2018-08-24 2021-06-30 Translate Bio, Inc. Methods for purification of messenger rna
WO2020106946A1 (en) 2018-11-21 2020-05-28 Translate Bio, Inc. TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR

Also Published As

Publication number Publication date
BE640639A (cg-RX-API-DMAC10.html) 1964-05-29
GB1072118A (en) 1967-06-14

Similar Documents

Publication Publication Date Title
CH422744A (de) Verfahren zur Herstellung neuer Polyoxyalkylenderivate
CH477448A (de) Verfahren zur Herstellung neuer Imidazolinderivate
AT258875B (de) Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate
AT244965B (de) Verfahren zur Herstellung neuer heterocyclischer Benzocycloheptan-Derivate
CH455828A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH475266A (de) Verfahren zur Herstellung neuer Benzoazacycloalkene
AT249047B (de) Verfahren zur Herstellung neuer Benzamidobenzanilid-Derivate
AT248030B (de) Verfahren zur Herstellung neuer 5'-Sulfoxyde
AT260202B (de) Verfahren zur Herstellung neuer Dibenzocycloheptaenverbindungen
CH407092A (de) Verfahren zur Herstellung basischer Fluoren-Derivate
CH437278A (de) Verfahren zur Herstellung neuer Oestranderivate
CH404674A (de) Verfahren zur Herstellung neuer 3-Alkenyl- und 3-Alkinyl-1-(5-nitrofurfuryliden-amino)-hydantoine
CH464206A (de) Verfahren zur Herstellung von -Aminobenzylpenicillinen
AT265520B (de) Verfahren zur Herstellung neuer Cephalosporinderivate
CH448049A (de) Verfahren zur Herstellung neuer Benzolsulfonylsemicarbazide
CH407119A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH480356A (de) Verfahren zur Herstellung neuer Azaphenthiazinderivate
CH450448A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
AT251777B (de) Verfahren zur Herstellung neuer Hendekapeptide
CH423050A (de) Verfahren zur Herstellung neuer Diacylaminoanthrachinone
CH420172A (de) Verfahren zur Herstellung neuer 5-Nitrofurylverbindungen
AT243795B (de) Verfahren zur Herstellung neuer Chinolizin-Derivate
CH410950A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH420167A (de) Verfahren zur Herstellung neuer N-Diphenylalkyl-norgranatan- und -nortropan-Derivate
AT248032B (de) Verfahren zur Herstellung neuer 3α-Phenyl-granatan-Derivate